View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 20, 2022

Enovis launches wearable device for knee and hip replacements

Arvis tracks from the surgeon’s viewpoint and provides information to the surgeon at the point of care.

Enovis has launched its wearable Arvis, standing for augmented reality visualisation and information system, device for orthopaedic navigation.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Earlier this month, the company’s subsidiary DJO Global completed the acquisition of Insight Medical and its US Food and Drug Administration (FDA)-cleared augmented reality platform, Arvis, which is designed for the specific needs of hip and knee replacement surgery.

The system is said to be the only proprietary, real-time, hands-free augmented reality (AR) technology that has been developed to provide orthopaedic surgeons with precision guidance visualisation while performing hip and knee surgery.

It is a self-contained surgical guidance device that is controlled by the surgeon and has been designed with a hands-free view of the procedure, which ensures surgeons can focus on their patients.

Arvis tracks from the surgeon’s viewpoint and provides information to the surgeon at the point of care.

By eliminating the need for single-use plastic instruments and consumables that require disposal, the device is said to be more environmentally friendly and sustainable than other technologies.

The company claims that the device is the first system with proprietary hardware to assist surgeons in placing hip and knee joint replacements precisely.

Enovis Surgical president and general manager Louie Vogt said: “Arvis was designed to provide surgeons with better information, more confidence and an enhanced surgical experience that integrates seamlessly into their procedural workflow without the need for obtrusive and unnecessary equipment.

“Arvis is significantly smaller, but powerful and precise, with a more economical price than large robotic systems.

“In turn, it can be adopted and scaled by a wide array of ambulatory surgical centres and hospitals, meaning more access to more patients wishing to experience the benefits of a technology-assisted knee or hip replacement.”

The company noted that Arvis is compatible with its EMPOWR Hip and Knee products, which include EMPOWR 3D, Acetabular system, Dual Mobility, Porous Knee and Partial Knee.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network